Kashi Clinical Laboratories

What Kashi Clinical Laboratories does

Kashi Clinical Laboratories is a privately held, accredited clinical laboratory headquartered in Portland, Oregon, operating for over 20 years with 11-50 employees. The company delivers specialty diagnostic testing across multiple verticals: HLA typing and histocompatibility for transplant matching, the Molecular Microscope Diagnostic System (MMDx) for transplant biopsy assessment, pharmacogenomics (PGx Comprehensive) and genetic disease-association panels, clinical pathology, toxicology, virology, environmental testing, and BioPharma clinical trial services. Its most differentiated technology is the MMDx platform, co-developed and commercialized in partnership with Thermo Fisher Scientific, which applies machine learning to gene expression data from biopsies to generate molecular scores that aid pathologists in detecting rejection and injury; the lung indication launched in October 2025.

The business operates a primarily B2B, sales-led model targeting hospitals, transplant centers, and physicians through the KashiPortal (kashiportal.com) for order entry and results, the order.kashilab.com self-serve store with publicly disclosed per-test pricing (single markers from $80 to comprehensive panels at $832), and phone-based ordering. A direct-to-consumer channel is operated through the BoneMarrowTest.com sub-brand, which sells at-home cheek swab private HLA testing kits for bone marrow, stem cell, and cord blood matching with results in 3-5 business days or 24 hours expedited. The company is HIPAA, GDPR, and CCPA compliant, holds clinical laboratory accreditation, and has no disclosed external funding, parent company, or M&A activity, indicating a founder-owned or closely-held operating business. Revenue, ownership, and management team details are not publicly disclosed, limiting visibility into financial scale.

Name

Kashi Clinical Laboratories

Legal name

Kashi Clinical Laboratories, LLC

Website

https://kashilab.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Kashi Clinical Laboratories is a Portland, Oregon-based accredited clinical lab serving hospitals, transplant centers, physicians, and BioPharma clients with HLA typing, MMDx transplant biopsy diagnostics, pharmacogenomics, genetic testing, toxicology, virology, and clinical pathology services across the United States.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Reference & Esoteric Testing Laboratories (HLAFAMAJ)

Keywords

• Clinical laboratory services
• HLA transplant testing
• Pharmacogenomics testing
• Molecular diagnostics
• Genetic testing services

Headquarters

HQ city

Portland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Laboratory Testing Services: Kashi generates revenue through providing clinical laboratory testing services across multiple specializations including HLA & transplant testing, genetic testing, clinical pathology, toxicology, and virology. Tests are ordered by healthcare providers and billed accordingly.
2. MMDx Partnership with Thermo Fisher: Revenue generated through partnership with Thermo Fisher Scientific for the MMDx Lung molecular diagnostic system, providing testing services for lung transplant biopsy assessment in the United States.
3. Direct-to-Consumer Private Testing: Private HLA testing kits sold directly to patients through BoneMarrowTest.com, enabling individuals to order testing for bone marrow, stem cell, or cord blood transplantation matching without joining donor registries.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

Kashi Clinical Laboratories is an accredited clinical laboratory that delivers diagnostic testing services across HLA and transplant testing, clinical pathology and genomics, genetic testing panels, pharmacogenomics (PGx), drug sensitivity and disease association testing, toxicology, virology, and environmental allergen testing. It also operates the MMDx™ Molecular Microscope Diagnostic System (in partnership with Thermo Fisher Scientific) for molecular transplant biopsy assessment, and offers at-home cheek-swab private HLA testing through BoneMarrowTest.com.

Product overview

Kashi Clinical Laboratories offers a comprehensive portfolio of clinical laboratory testing services organized around several core offerings: HLA & Transplant Testing (histocompatibility and immunogenetics), the Molecular Microscope Diagnostic System (MMDx™) using machine learning for transplant biopsy analysis, Clinical Pathology & Genomics (chemistry, immunology, hematology), Genetic Testing Panels (APOE, Cardiac Health, COMT, Mood Profile, MTHFR, Nutritional Health, Weight Management), Drug Metabolism/Pharmacogenomics (PGx Comprehensive), Drug Sensitivity & Disease Association Testing, Toxicology, Virology, Environmental Testing, and Pharma Services. The company also operates BoneMarrowTest.com as a patient-facing sub-brand for private HLA testing. Services are delivered through provider portals, online ordering platforms (order.kashilab.com), and the KashiPortal. The MMDx Lung product was launched in October 2025 in collaboration with Thermo Fisher Scientific.

Differentiator

Problem solved

Functional benefit

Brands

• MMDx®: Molecular Microscope Diagnostic System - a molecular diagnostic system for lung transplant rejection assessment, offered in partnership with Thermo Fisher Scientific

Products and services

• HLA & Transplant Testing Histocompatibility and immunogenetics testing services for transplantation, including HLA typing, crossmatching, antibody testing, KIR genotyping, and post-transplant monitoring for hospitals, transplant centers, and reference laboratories.
• Molecular Microscope Diagnostic System (MMDx™) - MMDx Lung Molecular diagnostic system analyzing gene expression from transplant biopsies using machine learning to produce molecular scores that aid pathologists in detecting rejection and injury. The MMDx Lung indication was launched in October 2025 in collaboration with Thermo Fisher Scientific and is offered in the United States.
• Clinical Pathology & Genomics Comprehensive clinical pathology testing including chemistry, immunology, hematology, coagulation, microbiology, and urinalysis for healthcare providers.
• Genetic Testing Panels Suite of genetic testing panels including APOE (Alzheimer's/Cardiovascular), Cardiac Health, COMT, Mood Profile, MTHFR, Nutritional Health, Weight Management, Bone Health, Celiac Disease, Mold and CIRS, and Comprehensive Genetic testing for various health conditions.
• Drug Metabolism Testing (PGx Comprehensive Panel) Pharmacogenomics testing panel analyzing Cytochrome P450 enzyme variants (CYP2D6, CYP2C19, CYP2C9), SLCO1B1, COMT, MTHFR, Factor II/V, VKORC1, OPRM1, and APOE to guide medication dosing and predict adverse drug reactions.
• Private HLA Testing At-home cheek swab-based HLA typing for bone marrow, stem cell, or umbilical cord blood transplantation matching, with results in 3-5 business days (or 24-hour expedited). Available without provider referral or public registry enrollment.
• Drug Sensitivity & Disease Association Testing HLA-based testing for drug hypersensitivity and autoimmune disease susceptibility, including Celiac Disease (DQ2/DQ8), Addison's Disease, Ankylosing Spondylitis, Behcet's Disease, Birdshot Chorioretinopathy, Graves' Disease, Multiple Sclerosis, Narcolepsy, Penicillin Hypersensitivity, Rheumatoid Arthritis, Sjögren's Syndrome, Systemic Lupus Erythematosus, and Abacavir/Carbamazepine/Allopurinol hypersensitivity.
• Toxicology Services Urine drug testing and toxicology screening services for healthcare providers, including specimen collection and shipping requirements.
• Virology Testing Molecular and serological virology testing services including PCR, viral culture, serological testing, and nucleic acid sequencing.
• Environmental Testing Environmental allergen and mold sensitivity testing services.
• Pharma Services Clinical trial support and pharmaceutical research services delivering precision diagnostics for clinical development to BioPharma companies.
• BoneMarrowTest.com Patient-facing portal for ordering private HLA testing kits for bone marrow, stem cell, or cord blood transplantation matching; a service of Kashi Clinical Laboratories.

Quantifiable outcome

• Results available in 3-5 business days (standard) or 24 hours (expedited) for private HLA testing

Named customers1 record

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• Thermo Fisher ScientificcoreTechnology or Integration · 9 October 2025Kashi Clinical Laboratories serves as the US partner for Thermo Fisher Scientific's MMDx Lung (Molecular Microscope Diagnostic System) testing. The partnership enables Kashi to offer advanced lung transplant biopsy assessment using machine learning-based gene expression profiling. Kashi processes specimens and provides results to US healthcare providers through this collaboration.
• BoneMarrowTest.comsupportingChannel Partner/ Reseller/ DistributorBoneMarrowTest.com is a service of Kashi Clinical Laboratories that enables direct ordering of private HLA testing kits for bone marrow, stem cell, and cord blood transplantation matching. The platform provides an alternative to public donor registries for individuals seeking private testing.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Sonic Healthcare: Sonic Healthcare runs a global network of medical laboratories offering routine and specialty clinical diagnostics. It is comparable to Kashi as a clinical-lab operator with overlapping test categories such as HLA, virology, and toxicology.
• Quest Diagnostics: Quest Diagnostics is a national reference lab with a broad HLA/transplant, genetic, PGx, and routine testing menu. It competes with Kashi for hospital system and physician-office routing decisions across overlapping testing categories.
• Labcorp: Labcorp is one of the two largest clinical reference laboratories in the United States, offering HLA typing, PGx, genetic, and routine clinical pathology services. It serves the same provider customer base as Kashi across transplant and pharmacogenomics, with much broader scale.
• Eurofins Scientific: Eurofins operates a global network of clinical and genetic testing laboratories, including HLA and pharmacogenomics. It overlaps with Kashi in clinical pathology, genetic, and specialty diagnostic testing, though at much broader scale.

Direct peers

• Invitae: Invitae is a genetic testing company offering hereditary disease, pharmacogenomic, and reproductive health panels. It competes with Kashi's genetic testing and PGx menu for physician orders in genetic and pharmacogenomic testing.
• Natera: Natera provides molecular testing with a focus on transplant rejection (e.g., Prospera) as well as women's health and oncology genetics. It directly competes with Kashi in molecular transplant diagnostics and adjacent genetic testing.
• Myriad Genetics: Myriad Genetics offers molecular and genetic testing, including pharmacogenomics and disease-risk panels. Its GeneSight and broader PGx/hereditary-cancer offerings overlap with Kashi's PGx and disease-association genetic testing.
• CareDx: CareDx is a transplant-focused diagnostics company offering molecular and antibody-based testing for organ rejection, kidney, heart, and lung transplant surveillance. It competes most directly with Kashi in HLA and transplant molecular diagnostics, particularly around MMDx-adjacent offerings.

Others

• Thermo Fisher Scientific: Thermo Fisher is the technology partner for MMDx Lung that Kashi operates; it also sells the Applied Biosystems HLA/transplant and qPCR instrument portfolio broadly. It is comparable as both a partnership counterparty and an adjacent supplier in Kashi's transplant diagnostic stack.
• Bio-Rad Laboratories: Bio-Rad supplies HLA reagents, controls, and instrumentation used by histocompatibility labs including Kashi and competitors. While not a direct competitor in clinical lab services, it is a key supplier in Kashi's HLA testing workflow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCbOvqd0UldhnlRUlNIWasw
• LinkedInlinkedin.com/company/kashi-clinical-laboratories-inc-
• Instagraminstagram.com/kashilab

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kashi Clinical Laboratories